A detailed history of Thompson Investment Management, Inc. transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Thompson Investment Management, Inc. holds 1 shares of LUCD stock, worth $1. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$1
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$0.81 - $1.52 $0 - $1
1 New
1 $0

Others Institutions Holding LUCD

About Lucid Diagnostics Inc.


  • Ticker LUCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 38,568,500
  • Market Cap $38.6M
  • Description
  • Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...
More about LUCD
Track This Portfolio

Track Thompson Investment Management, Inc. Portfolio

Follow Thompson Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Investment Management, Inc. with notifications on news.